Picard Medical, Inc. Financing Cash Flow
Picard Medical, Inc. (PMI) reported Financing Cash Flow of -$6.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-19
- Picard Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.25M, a 45.30% decline year-over-year.
- Picard Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$7.52M, a 365.42% decline year-over-year.
- Picard Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $13.02M, a 302.63% increase year-over-year.
- Picard Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $8.95M, a 254.00% increase year-over-year.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$6.28M 10-Q · filed 2026-08-19 | $6.74M derived: sum of 3 quarters · filed 2026-08-19 | $15.69M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | -$7.52M 10-Q · filed 2026-05-15 | $5.50M derived: sum of 2 quarters · filed 2026-05-15 | $14.44M derived: sum of 3 quarters · filed 2026-05-15 | $16.72M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $13.02M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $21.97M derived: sum of 2 quarters · filed 2026-05-01 | $24.24M derived: sum of 3 quarters · filed 2026-08-19 | $27.08M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $8.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $11.23M derived: sum of 2 quarters · filed 2026-08-19 | $14.06M 10-Q · filed 2025-11-14 | $17.29M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $5.11M 10-Q · filed 2026-08-19 | $8.35M derived: sum of 3 quarters · filed 2026-08-19 | $10.87M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $2.83M 10-Q · filed 2026-05-15 | $6.07M derived: sum of 2 quarters · filed 2026-05-15 | $8.60M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $3.23M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $5.76M derived: sum of 2 quarters · filed 2026-05-01 | $11.74M S-1/A · filed 2026-05-01 | |
| 2024-09-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $8.51M 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $5.98M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |